MetaCap

Cytek Biosciences Inc. Company Profile

NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

5.36+0.02 (+0.37%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Cytek Biosciences at a glance

Cytek Biosciences Inc. (NASDAQ: CTKB) is a Biotechnology: Laboratory Analytical Instruments company in the Industrials sector headquartered in Fremont, CA. Cytek Biosciences is led by Dr. Wenbin Jiang Ph.D. and employs about 682 people. The company's shares have traded publicly since 2021.

At a market capitalization of $694.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001831915, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Cytek Biosciences do?

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Business description based on the company's public filings.

Company information

Legal name
Cytek Biosciences Inc.
Ticker
NASDAQ: CTKB
Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Dr. Wenbin Jiang Ph.D.
Employees
682
Headquarters
47215 Lakeview Blvd, Fremont, CA, United States
Phone
877 922 9835
IPO year
2021
Market cap
$694.11M
SEC CIK
0001831915
Latest annual report
10-K · Feb 26, 2026

Companies similar to Cytek Biosciences

CTKB peer companies
CompanyPrice% ChgMarket capCompare
PACBPacific Biosciences of California Inc.2.30-15.44%$714.91Mvs CTKB
EYPTEyePoint Inc.3.46+4.22%$290.09Mvs CTKB
LABStandard BioTools Inc.0.6703-1.24%$263.15Mvs CTKB
NAUTNautilus Biotechnology Inc.1.82-7.14%$231.60Mvs CTKB
QTRXQuanterix Corporation3.21-3.46%$151.81Mvs CTKB
SEERSeer Inc. Class A2.17-1.81%$120.16Mvs CTKB
ALMRAlamar Biosciences Inc.25.91-6.70%$1.80Bvs CTKB
BRKRBruker Corporation57.92-3.01%$8.82Bvs CTKB

Related